caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1144489022

Marianna StrakhanM.D.

Hematology-OncologyClifton, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (4)

CCN 310001
Hospital
CCN 310006
Hospital
CCN 310012
Hospital
CCN 310017
Hospital
REFERRAL NETWORK

Where Marianna Strakhan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION2444
ALEXIS, KARENZA2451
Tarek Elrafei
Hematology-Oncology · Bronx, NY
1571
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION90453
Tarek Elrafei
Hematology-Oncology · Bronx, NY
1980
ALEXIS, KARENZA1741
MONTEFIORE MEDICAL CENTER1663
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION1322
Iuliana Shapira
Hematology-Oncology · Little Silver, NJ
1124
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,003
Unique beneficiaries
—
Total services
38,338
Distinct HCPCS
35
Medicare payment
$184K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 301 Hematology-Oncology providers in NJ — above median (cohort median 3,501).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
944
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
33
Brand share
48.9%
Top prescribed drugs
Apixaban117 claims
Anastrozole104 claims
Rivaroxaban70 claims
Epoetin Alfa64 claims
Hydroxyurea51 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$125
Payment records
1
By payment type
Food and Beverage$125